Research and Development

Showing 15 posts of 9599 posts found.

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
Roche

Roche to acquire digital pathology specialists

August 23, 2010 Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010 Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …

Novartis and Quark sign gene silencing deal

August 19, 2010 Research and Development Novartis, Quark, SiRNA, rnai

Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …

Cell therapy industry partnership launched

August 18, 2010 Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …

Contract research news in brief

August 18, 2010 Research and Development Anavex, Cyprotex, Synexus

UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …

Lilly abandons late stage Alzheimer’s drug

August 17, 2010 Research and Development Alzheimer's, lilly

Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
StemCellPinheadWeb

Regenerative medicine: small steps towards the great leap forward

August 16, 2010 Research and Development GSK, Pfizer, Stem cells, regenerative medicine

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …

Merck signs Alzheimer’s deal with Alectos

August 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, Merck & Co

Merck has entered a $289 million agreement with Canadian company Alectos Therapeutics in a bid to find new Alzheimer’s drugs. …
Amgen

Amgen’s Vectibix fails late stage trial

August 12, 2010 Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer

Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …

Pharminox promotes Dr Marc Hummersone

August 12, 2010 Research and Development Pharminox, appointment, research and development

Nottingham, UK-based cancer drug discovery and development company Pharminox has appointed Dr Marc Hummersone as research director. Marc first joined …

US biotech investment doubles

August 11, 2010 Research and Development biotech, funding

Investment in the beleaguered US biotechnology sector shot up in the second quarter of this year, but analysts say it’s …

Quintiles relocates European headquarters

August 11, 2010 Research and Development, Sales and Marketing Quintiles

Contract research organisation and pharma services company Quintiles is moving its European headquarters to Reading in the UK. Previously based …

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1

August 11, 2010 Research and Development Kinapse, life sciences, pharma

Valuations are essential components of effective transactions in the life sciences industry

Sanofi signs personalised medicine alliance

August 11, 2010 Research and Development Sanofi-Aventis, Scripps Genomic Medicine, genomics

Sanofi-Aventis has signed a personalised medicine research alliance with US not-for-profit company Scripps Genomic Medicine. The company is part of …
The Gateway to Local Adoption Series

Latest content